Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6886 AL 6900

Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects

Kawakita S, Mandal K, Mou L, Mecwan MM, Zhu Y, Li S, Sharma S, Hernandez AL, Nguyen HT, Maity S, de Barros NR, Nakayama A, Bandaru P, Ahadian S, Kim HJ, Herculano RD, Holler E, Jucaud V, Dokmeci MR, Khademhosseini A.

Small. 2022 Sep;18(39):e2201401. doi: 10.1002/smll.202201401. Epub 2022 Aug 17.

Tacrine Derivatives in Neurological Disorders: Focus on Molecular Mechanisms and Neurotherapeutic Potential

Mitra S, Muni M, Shawon NJ, Das R, Emran TB, Sharma R, Chandran D, Islam F, Hossain MJ, Safi SZ, Sweilam SH.

Oxid Med Cell Longev. 2022 Aug 18;2022:7252882. doi: 10.1155/2022/7252882. eCollection 2022.

Pisa syndrome in dementia with Lewy bodies: A Chinese multicenter study

Su Z, Liu S, Chen G, Gan J, Bao X, Zhu H, Wang X, Wu H, Ji Y.

Parkinsonism Relat Disord. 2022 Oct;103:50-55. doi: 10.1016/j.parkreldis.2022.08.021. Epub 2022 Aug 24.

Recent Advancements in CNS Acting Drugs: A Step Towards End of Illness

Javed MN, Pottoo FH, Naim MJ, Chawla PA.

CNS Neurol Disord Drug Targets. 2022;21(10):882-883. doi: 10.2174/187152732110220722112205.

Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discovery

Cetin S, Knez D, Gobec S, Kos J, Pišlar A.

Biomed Pharmacother. 2022 May;149:112924. doi: 10.1016/j.biopha.2022.112924. Epub 2022 Apr 8.

Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature

Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI.

Drug Des Devel Ther. 2022 Aug 31;16:2919-2931. doi: 10.2147/DDDT.S367229. eCollection 2022.

Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease

Goyal A, Verma A, Dubey N, Raghav J, Agrawal A.

J Food Biochem. 2022 Dec;46(12):e14415. doi: 10.1111/jfbc.14415. Epub 2022 Sep 15.

Microglial ion channels: Key players in non-cell autonomous neurodegeneration

Sarkar S.

Neurobiol Dis. 2022 Nov;174:105861. doi: 10.1016/j.nbd.2022.105861. Epub 2022 Sep 14.

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

Jiao F, Zhou B, Meng L.

CNS Neurosci Ther. 2023 Jan;29(1):37-59. doi: 10.1111/cns.13985. Epub 2022 Oct 2.

Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's disease

Lipton SA.

Free Radic Biol Med. 2022 Nov 20;193(Pt 1):171-176. doi: 10.1016/j.freeradbiomed.2022.10.272. Epub 2022 Oct 13.

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Edison P.

Mol Psychiatry. 2023 Jan;28(1):217-229. doi: 10.1038/s41380-022-01792-4. Epub 2022 Oct 18.

Challenges in diagnosis and management of delirium in Lewy body disease

Richardson S, Lawson RA, Price A, Taylor JP.

Acta Psychiatr Scand. 2023 May;147(5):475-480. doi: 10.1111/acps.13514. Epub 2022 Nov 4.

Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders

Seibyl JP.

J Nucl Med. 2023 Jan;64(1):12-19. doi: 10.2967/jnumed.122.264773. Epub 2022 Oct 27.

The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence

Emekli-Alturfan E, Alturfan AA.

Mol Biol Rep. 2023 Jan;50(1):815-828. doi: 10.1007/s11033-022-07925-w. Epub 2022 Nov 3.

Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder

Nakhal MM, Aburuz S, Sadek B, Akour A.

Molecules. 2022 Oct 23;27(21):7174. doi: 10.3390/molecules27217174.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias